Philip Morris International (NYSE:PM) Cut to Hold at Wall Street Zen

Philip Morris International (NYSE:PM - Get Free Report) was downgraded by Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Saturday.

PM has been the subject of a number of other research reports. UBS Group upgraded shares of Philip Morris International from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $130.00 to $170.00 in a research report on Friday, April 25th. Jefferies Financial Group started coverage on shares of Philip Morris International in a research report on Wednesday. They set a "buy" rating and a $220.00 target price for the company. Bank of America lifted their target price on shares of Philip Morris International from $182.00 to $200.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Citigroup lifted their target price on shares of Philip Morris International from $188.00 to $200.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, Morgan Stanley restated an "overweight" rating and set a $182.00 target price (up previously from $156.00) on shares of Philip Morris International in a research report on Thursday, April 24th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $185.73.

Philip Morris International Stock Performance

PM stock traded down $1.26 during trading on Friday, reaching $179.73. 3,430,602 shares of the company were exchanged, compared to its average volume of 5,634,992. The company has a market cap of $279.75 billion, a P/E ratio of 37.06, a PEG ratio of 2.63 and a beta of 0.51. Philip Morris International has a 52-week low of $104.84 and a 52-week high of $186.69. The stock's 50 day moving average price is $178.05 and its 200 day moving average price is $156.52.

Philip Morris International (NYSE:PM - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $1.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.61 by $0.08. The company had revenue of $9.30 billion during the quarter, compared to analysts' expectations of $9.10 billion. Philip Morris International had a net margin of 8.43% and a negative return on equity of 122.40%. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.50 earnings per share. As a group, equities research analysts forecast that Philip Morris International will post 7.14 EPS for the current year.

Hedge Funds Weigh In On Philip Morris International

Institutional investors and hedge funds have recently bought and sold shares of the stock. Kelly Lawrence W & Associates Inc. CA acquired a new position in Philip Morris International during the first quarter worth approximately $30,000. CBIZ Investment Advisory Services LLC increased its position in Philip Morris International by 405.0% during the first quarter. CBIZ Investment Advisory Services LLC now owns 202 shares of the company's stock worth $32,000 after purchasing an additional 162 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in Philip Morris International during the first quarter worth approximately $34,000. Pacifica Partners Inc. increased its position in Philip Morris International by 115.0% during the first quarter. Pacifica Partners Inc. now owns 215 shares of the company's stock worth $35,000 after purchasing an additional 115 shares during the last quarter. Finally, Redmont Wealth Advisors LLC acquired a new position in Philip Morris International during the first quarter worth approximately $35,000. Institutional investors and hedge funds own 78.63% of the company's stock.

Philip Morris International Company Profile

Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.